69 results
8-K
EX-99.1
GRTX
Galera Therapeutics Inc
28 Mar 24
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
7:06am
safety and efficacy of Galera’s product candidates and their regulatory and clinical development; Galera’s ability to fund its operating expenses … lawsuits; environmental, health and safety laws and regulations; Galera may not be able to enter into any desired strategic alternative or partnership
8-K
EX-99.1
GRTX
Galera Therapeutics Inc
14 Nov 23
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
12:00am
: the expectations surrounding the continued advancement of Galera’s product pipeline; the potential safety and efficacy of Galera’s product candidates … obtained from clinical trials and product liability lawsuits; environmental, health and safety laws and regulations; Galera’s recent reduction in force
8-K
EX-99.1
fc083 3wbnsv
31 Oct 23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
7:10am
8-K
3ofjch 8g4wmv1b63wl
31 Oct 23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
7:10am
8-K
EX-99.1
8f7mgq 7tht
14 Aug 23
Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
7:10am
8-K
5762v 3uoz
10 Aug 23
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
8:00am
8-K
EX-99.1
3jd8g5irgqn2dnlhdv
10 Aug 23
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
8:00am
8-K
EX-99.1
7oodd 0181qbmv9ir2
11 May 23
Galera Reports First Quarter 2023 Financial Results and Recent Corporate
7:11am
8-K
EX-99.1
5ssrfdkn9ssve7xhhkcf
12 Dec 22
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
8:00am
8-K
EX-99.1
062u3n uadvejw
9 Nov 22
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
7:06am
8-K
EX-99.2
wis136s o9ddb
26 Oct 22
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
1:41pm
8-K
EX-99.1
mlruq1qvuvsmnhalg0ds
26 Oct 22
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
1:41pm
8-K
EX-99.1
r53ylrbc33fv1pu8hfdi
9 Aug 22
Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
7:00am